Barclays raised a price target and Cantor Fitzgerald reiterated an Overweight rating on Tenet Healthcare.
4 reports, 2 independent
Updated Aug 1
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays raised a price target and Cantor Fitzgerald reiterated an Overweight rating on Tenet Healthcare.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Rating firms Barclays and Cantor Fitzgerald updated their outlook on Robinhood Markets Inc.1 source
Barclays and Cantor Fitzgerald issued rating updates on Tenet Healthcare stock.1 source
Keep exploring
The entities involved
-
Tenet Healthcare
American healthcare company
-
Barclays
British bank
-
Cantor Fitzgerald
American financial services company
- The event reports that Brooke Rollins serves as Trump's Agriculture Secretary and notes that Lutnick previously ran Cantor Fitzgerald.
- Agilysys CEO Ramesh Srinivasan sold significant company shares, with the transaction disclosed via filings with the SEC, concurrent with a rating from Cantor Fitzgerald.
Related events
- Multiple financial firms, including Cantor Fitzgerald and William Blair, issued rating updates and price targets for various stocks on August 10, 2026.
- Cantor Fitzgerald reiterated an overweight rating on BioPharma shares, reducing the target price and setting a buy rating.
- Cantor Fitzgerald restated an overweight rating and Royal Bank of Canada reduced its price objective for United Therapeutics.
- Cantor Fitzgerald raised its price target and gave an overweight rating for SOL Strategies Inc. on October 11, 2026.
- Multiple financial firms (Barclays, UBS, Morgan Stanley, Jefferies) issued rating and price target updates for Equity Lifestyle Properties.